Summary
The provided FDA label excerpts do not contain any information about a Vascepa Savings Card/AmarinCARE eligibility, pricing (e.g., $9/90-day fill), copay limits, activation/expiration, pharmacy participation, restricted states, or eligibility verification. Therefore, all such claims are unsupported by the supplied prescribing information.
Category Scores
Accurate Statements
Unsupported Statements
Vascepa (icosapent ethyl) offers a Vascepa Savings Card program through which eligible patients can pay as little as $9 per 90-day prescription fill for commercial insurance.
The supplied prescribing information excerpts do not mention a Savings Card, pricing amounts, or $9/$90-day terms.
The Vascepa Savings Card program provides copay assistance up to $18,000 annually.
The supplied prescribing information excerpts do not mention copay assistance amounts or annual limits.
Patients must have private commercial insurance that covers Vascepa to qualify for the Vascepa Savings Card.
The supplied prescribing information excerpts do not mention qualification criteria related to insurance type/coverage.
Patients must not be enrolled in government programs such as Medicare, Medicaid, TRICARE, or VA benefits to qualify for the Vascepa Savings Card.
The supplied prescribing information excerpts do not mention government program exclusions or Savings Card eligibility criteria.
Patients must live and get prescriptions in the US or Puerto Rico to qualify for the Vascepa Savings Card.
The supplied prescribing information excerpts do not mention geographic eligibility requirements.
The prescription must come from a licensed US physician to qualify for the Vascepa Savings Card.
The supplied prescribing information excerpts do not mention physician licensing/location requirements for eligibility.
No income limits apply for qualification for the Vascepa Savings Card.
The supplied prescribing information excerpts do not mention income-based eligibility criteria for the Savings Card.
Patients cannot use the Vascepa Savings Card with government insurance.
The supplied prescribing information excerpts do not mention rules about using the Savings Card with government insurance.
The Vascepa Savings Card cannot be used where prohibited by law.
The supplied prescribing information excerpts do not mention legal/prohibition-related limitations for use of the Savings Card.
Government-insured patients do not qualify for the Vascepa Savings Card.
The supplied prescribing information excerpts do not mention government-insured eligibility status for the Savings Card.
Government-insured patients may check AmarinCARE for free medication options if they meet low-income criteria (household income at or below 400% of the federal poverty level) and lack other coverage.
The supplied prescribing information excerpts do not mention AmarinCARE, free medication options, or specific low-income eligibility thresholds.
To apply for AmarinCARE, patients can apply via phone or patient services.
The supplied prescribing information excerpts do not mention how to apply for AmarinCARE (phone/patient services) or contact pathways.
The Vascepa Savings Card can be downloaded as a digital card from the official Vascepa site or obtained as a physical card from a pharmacy or doctor.
The supplied prescribing information excerpts do not mention card formats (digital/physical) or distribution channels.
The Vascepa Savings Card can be activated online or by phone at 1-877-304-3185.
The supplied prescribing information excerpts do not mention activation methods or any phone number.
The Vascepa Savings Card works at most US pharmacies.
The supplied prescribing information excerpts do not mention pharmacy participation breadth.
Savings from the Vascepa Savings Card apply at point-of-sale.
The supplied prescribing information excerpts do not mention point-of-sale application mechanics for savings.
The Vascepa Savings Card expires after 48 months.
The supplied prescribing information excerpts do not mention card expiration duration.
The Vascepa Savings Card auto-renews for eligible patients.
The supplied prescribing information excerpts do not mention auto-renewal.
Applications for the Vascepa Savings Card may be denied if the insurance is government-based.
The supplied prescribing information excerpts do not mention application denial criteria.
Applications for the Vascepa Savings Card may be denied if the pharmacy does not participate in the program.
The supplied prescribing information excerpts do not mention pharmacy participation or denial criteria.
Applications for the Vascepa Savings Card may be denied if the patient is in a restricted state or program.
The supplied prescribing information excerpts do not mention restricted states/programs.
Pharmacists can verify Vascepa Savings Card eligibility instantly via the card system.
The supplied prescribing information excerpts do not mention eligibility verification procedures for pharmacists or any card system.
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
High
The claims are specific to patient eligibility and cost/access programs. None of this program-specific information is supported by the supplied FDA prescribing information excerpts, so the risk is that patients could receive incorrect guidance about eligibility/costs and potentially delay access to therapy.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Savings Card/AmarinCARE program eligibility, pricing, activation, and operational details are not present in the provided FDA label excerpts.
Suggested Improvement
Limit the response to label-supported content from the provided prescribing information (e.g., indications, dosing, contraindications, warnings/precautions). Remove or clearly qualify all Savings Card/AmarinCARE program claims unless the exact label-supported text addressing these programs is provided.